Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria
Overview
Authors
Affiliations
Background: Risk of cognitive impairment is increased among persons with high or low body mass index in HIV- and HIV+ populations in resource-rich settings. We examined this association among HIV+ patients in 3 resource-limited settings.
Methods: This secondary analysis included data of 761 HIV+ volunteers pooled from 3 prospective cohort studies conducted in China (n = 404; 53%), India (n = 200; 26%), and Nigeria (n = 157; 21%). World Health Organization (WHO) weight classifications were based on body mass index. T scores, adjusted for demographics and practice effects, were derived from a 7-domain neuropsychological battery. Neurocognitive impairment (NCI) was defined as global deficit score of ≥0.5.
Results: Overall, prevalence of NCI at baseline was 27.7% (similar across all cohorts). The overweight/obese and underweight constituted 37.3% and 15.5% of the total participants, respectively. In a multivariable logistic regression of pooled longitudinal data, adjusting for clinical and demographic variables, the odds of global NCI were 38% higher among the overweight/obese as compared to normal weight participants [odds ratio: 1.38 (95% confidence interval: 1.1 to 1.72); P = 0.005]. Similarly, the odds of global NCI were 39% higher among the underweight as compared to normal weight participants [odds ratio: 1.39 (95% confidence interval: 1.03 to 1.87); P = 0.029].
Conclusions: NCI among HIV-1-infected patients was more prevalent in both overweight/obese and underweight than normal weight individuals in 3 resource-limited settings, confirming observations in resource-rich settings. Mechanisms underlying these associations are unclear but likely differ for underweight and overweight persons.
Neuroimaging advances in neurocognitive disorders among HIV-infected individuals.
Wang H, Jiu X, Wang Z, Zhang Y Front Neurol. 2025; 16:1479183.
PMID: 40017532 PMC: 11864956. DOI: 10.3389/fneur.2025.1479183.
Jumare J, Dakum P, Sam-Agudu N, Memiah P, Nowak R, Bada F BMC Endocr Disord. 2023; 23(1):160.
PMID: 37507703 PMC: 10375691. DOI: 10.1186/s12902-023-01419-x.
Chebrolu P, Sangle S, Nimkar S, Salvi S, Chavan A, Kulkarni V Diabetes Metab Syndr. 2022; 16(7):102551.
PMID: 35777254 PMC: 9912190. DOI: 10.1016/j.dsx.2022.102551.
Tamirat K, Tesema G, Tessema Z HIV AIDS (Auckl). 2021; 13:415-423.
PMID: 33883949 PMC: 8055467. DOI: 10.2147/HIV.S299538.
Britton M, Porges E, Bryant V, Cohen R Alcohol Clin Exp Res. 2020; 45(2):290-306.
PMID: 33296091 PMC: 9486759. DOI: 10.1111/acer.14530.